Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

CytoDyn provides update on its HIV dose-escalating monotherapy trial of leronlimab

Aug. 16, 2019

ZL-0580: a novel BRD4-selective small molecule that suppresses HIV

Aug. 9, 2019

HIV: exosomes potentiate inflammation in bystander cells

Aug. 6, 2019

AAV-eCD4-Ig protects rhesus macaques from SIVmac239 challenges

Aug. 2, 2019

ViiV Healthcare presents week 96 data from ongoing phase III BRIGHTE study

July 29, 2019

Researchers test nanochannel delivery implant for HIV drug cabotegravir

July 26, 2019

TILRR is a new therapeutic target for treating vaginal HIV-1 infection

July 26, 2019

Orion's OB-002 shown to be more potent than maraviroc in a model of HIV infection

July 25, 2019

Preliminary phase I data for the long-acting HIV capsid inhibitor GS-6207

July 25, 2019

Merck & Co. presents clinical data for MK-8591 in patients with HIV-1 infection

July 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...